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The proteinuna observed in diseases which pre-
dominantly affect glomeruli is not unexpected. Pre-
sumably, the disease process with its attendant se-
vere, structural alterations increases the per-
meability of the glomeruli to protein, and the
subsequent increase in filtered load of protein over-
whelms the tubular reabsorptive capacity [1]. Pro-
teinuria also occurs, however, in nonglomerular
renal diseases. For example, in man with only mod-
erately advanced pyelonephritis, it is not unusual
for protein excretion rates to range between I and 2
g/day [2], and sometimes the proteinuria is of such a
magnitude that it results in a nephrotic syndrome
[3]. Why such proteinuria occurs is not clear, be-
cause pathologic alterations of the glomeruli are not
characteristic of pyelonephritis and need not be
present for proteinuria to occur.
The present studies were undertaken in the rat to
investigate the mechanisms responsible for the pro-
teinuria observed in renal diseases which do not af-
fect the glomeruli primarily. The results indicate
that such proteinuria occurs in the absence of any
underlying pathologic process and thus is not de-
pendent on anatomic abnormalities. Rather, it ap-
pears to be the consequence of adaptive changes
which occur in residual nephrons when total nephron
population is reduced. It is suggested that the al-
terations in glomerular permselectivity characteris-
tics which were observed in animals with reduced
nephron mass, permit increased passage of plasma
proteins across the glomerular barrier and that it
is this change which is primarily responsible for the
increased urinary protein excretion observed in
nonglomerular renal diseases.
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Methods
Animal models. All studies were performed on fe-
male Sprague-Dawley rats ranging in age from 6 to 9
months and in weight from 250 to 300 g. Animals
were divided into groups designated as stages I, IA,
II, and III. The control studies were performed on
normal (stage I) rats that were age-matched litter-
mates of the animals used for the remainder of the
studies. Stage IA animals had had unilateral ne-
phrectomy but were otherwise normal. The stage-TI
and stage-Ill animals had an experimentally in-
duced lesion in one kidney. This was either unilater-
al pyelonephritis, induced by previously described
methods [4], or surgical reduction in mass produced
either by ligating several branches of the renal ar-
tery to one kidney [5] or by excision of the upper
and lower poles of one kidney [6]. In stage-TI ani-
mals, the contralateral kidney was left intact; in
stage-Ill rats it was removed. Whenever possible,
animals were studied on at least two occasions, in
stage II and again in stage III, the normal kidney
being removed immediately after the stage-Il study.
In the remaining stage-Ill animals, the unilateral
renal lesion and contralateral nephrectomy were
performed in a single procedure, All animals were
allowed to recover for 10 to 14 days after each sur-
gical procedure before they were studied. Thus,
even in the animals investigated in stage II and
again in stage Ill, all the physiologic studies were
completed within 28 days of the initial surgery.
Experimental techniques. Measurements of
GFR, of quantitative and qualitative protein excre-
tion, and of glomerular permselectivity to 25I-la-
beled polydisperse polyvinyl pyrrolidone ('251-PVP)
were undertaken in rats in each of the four groups of
animals. For these studies, femoral artery, tail vein,
ureteric, and bladder catheters were inserted under
light ether anesthesia [4]. The animals were then re-
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strained in a normal position in a bivalved plastic
cylinder and were allowed to recover fully from the
anesthetic for at least 2 hours before any collections
were begun [4].
Measurements of GFR. In the studies of protein
excretion, carboxyl-'4C-inulin was used to measure
GFR [4]. In the experiments involving 1251-PVP, un-
labeled inulin was used, inulin concentrations being
measured with anthrone [7]. A minimum of two
urine collections, each of at least 30 mm's duration,
was used for these measurements. Mean plasma in-
ulin concentrations were calculated from concen-
trations measured at the beginning, midpoint, and
end of each clearance period or at 15-mm intervals
in any clearance period that exceeded 30 mm.
Quantitative protein determinations. Protein ex-
cretion rates were measured on timed urine samples
collected into tubes immersed in iced water. At the
end of these clearance periods, a 200-id sample of
arterial blood was obtained for determination of to-
tal serum protein. The urine samples were centri-
fuged at 2,000 rpm for 10 mm at 4° C. The sediment
was examined for red blood cells and the super-
natant tested for hemoglobin (Hemastix-Ames, Elk-
hart, Indiana). If either was found, the sample was
discarded. All other urine samples were analyzed
for total protein content by adding 50 or 100 d of
supernatant from the centrifuged urine to a conical
test tube containing 200 pi of 20% trichloracetic
acid (TCA) and 200 jsl of 0.15 M sodium chloride.
The solution was mixed and examined for turbidity.
If none was present, successive 50-1d samples of
urine were added until turbidity appeared. The total
volume of urine added was recorded, and TCA was
added to a final concentration of 10%. After 10 mm,
the tubes were centrifuged at 3,000 rpm for 25 mm
at room temperature, and the supernatant fluid was
removed. The precipitate was redissolved in 200 jsl
1.0 N sodium hydroxide and was diluted to a known
volume, usually 2 ml, with 0.15 M sodium chloride.
The protein content was then measured by using
standard methodology [8]. Serum proteins were de-
termined by using the same methods after appropri-
ate dilutions of the original serum. Standards con-
taining 25, 50, and 100 g of normal human serum
protein were run in parallel with urine and serum
samples.
In preliminary studies, known amounts of protein
over an appropriate range of concentrations were
added to urine and serum samples, and analyses
were performed by using the methods outlined
above. Protein recovery averaged 101.7 4.7%.
The coefficient of variation for the method was sub-
sequently calculated from more than 250 samples,
each analyzed in duplicate, and was less than 4%.
Qualitative protein determinations. Rat urine
samples, collected for timed periods of up to 10
hours in containers surrounded by iced water, was
lyophilized. The lyophilized urine was then dis-
solved in 1 ml of water and was passed through a
Sephadex G-25 column equilibrated with 0.15 M so-
dium chloride plus 0.02 M phosphate buffer with a
pH of 7.3 at 4° C. All the tubes of eluate that con-
tained protein were pooled and total volume was re-
duced by positive pressure dialysis. This concen-
trated protein was used for estimation of total pro-
tein, for paper and cellulose acetate electrophoresis
of the protein using standard methodology, for im-
munologic estimation of albumin, for column chro-
matography, and for measurement of total carbohy-
drate content of the protein.
For the immunochemical estimation of albumin in
both urine and sera samples, rat serum albumin
(Miles Laboratories, Inc., Elkhart, Indiana) was pu-
rified by column chromatography on Sephadex G-
200 eluting with 0.15 M sodium chloride plus 0.02 M
phosphate buffer (pH, 7.3). An antiserum to this al-
bumin was produced in a rabbit [9]. On immuno-
electrophoresis, this antiserum gave one precipi-
tation band with purified rat serum albumin but two
bands with whole rat serum, the second band being
to an a-globulin. Starch block electrophoresis of
whole rat serum provided an a-globulin fraction,
which was used to absorb the rabbit antiserum. On
immunoelectrophoresis, the absorbed antiserum
gave only one band with rat serum albumin, whole
rat serum, or concentrated rat urine protein. A
quantitative precipitin curve was then prepared us-
ing standard methodology and was used to estimate
the amount of albumin in the urine and serum sam-
ples. Known dilutions of the sample were added to
the antiserum, and the amount of protein in the pre-
cipitate was determined, testing the supernate to
ensure that precipitation had occurred in the zone
of antibody excess. Two different dilutions of the
unknown sample were tested at the same time as
two different known amounts of rat serum albumin.
With this method, albumin recovery averaged 98.8
5.7%, with the coefficient of variation of the
method being less than 8%.
Column chromatography of the G-25 eluate of
urinary proteins was performed at room temper-
ature using 0.15 M sodium chloride and 0.02 M phos-
phate buffer (pH, 7.3) as protein solvent and for elu-
tion. The protein, in amounts of 5 to 20 mg dis-
solved in 0.2 to 0.5 ml solvent, was added to 2.7 x
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90-cm columns of Sephadex G-200. Each protein
sample also contained 0.1 mg of 1251-labeled bovine
serum albumin. The eluate was collected in 3.8 ml
samples, the optical density (at 280 nM) of each
sample as well as its isotope activity being mea-
sured.
The carbohydrate content of the serum and urine
protein G-25 eluates was measured with orcinol re-
agent [10]. The sugar standard contained equimolar
amounts of galactose and mannose.
Measurement of glomerular permselectivity to
polydisperse polyvinyl pyrrolidone (PVP). Identical
methodology to that described previously [11] was
used except the volumes of plasma and urine sub-
jected to column chromatography were reduced to
100 l, these samples being diluted with eluate to a
final volume of 2 ml before being applied to the col-
umns. In addition, the dose of '251-PVP that was ad-
ministered to the animals was increased to 40 to 50
sCi/g body wt to obtain adequate counting rates
from the smaller plasma volumes.
Other methods. Mean arterial blood pressure was
measured in representative stage-I, -IA, -II, and -III
animals by a manometer connected to the catheter
placed in the femoral artery. Semiquantitative mea-
surements of glomerular polyanion were made in
stage-I, -IA, and -III animals. Animals were killed by
a blow on the head, and the kidneys were removed
quickly. Harvested kidneys were quartered and
fixed in buffered formalin (pH, 7.4) for 48 hours.
Sections were then prepared and stained at pH 1.8
with either alcian blue or colloidal iron [12—14]. Sec-
tions from normal rat kidneys known to stain
strongly for glomerular polyanion were run as a
control for staining with each batch of kidneys eval-
uated. Slides were randomized in double-blind fash-
ion. They were then graded for the degree of poly-
anion staining by three observers who indepen-
dently examined 20 glomeruli from each kidney.
Every glomerulus was assigned a score from 0 to 5
(0 equaled no staining; 5, intense staining) by each
observer. The final score for any kidney was then
derived by averaging the 60 observations from that
kidney.
Statistical analyses. All values are expressed as
mean SD unless stated otherwise. Values of P
were calculated by Student's t test using either in-
dependent or paired data as appropriate [15].
Results
Quantitative protein excretion: (1) Stage-I stud-
ies. Initial studies demonstrated that proteinuria in-
creased with age in rats older than 1 year of age, this
increase being substantial towards the end of the
second year of life. There was, however, no corre-
lation between age and the degree of proteinuria in
stage-I animals aged less than 1 year. Nor was a
progressive increment in proteinuria observed in
any animal when protein excretion rate was mea-
sured on at least four occasions in each of nine
stage-I rats over a 6-month period beginning at age 5
months. Based on these observations, all sub-
sequent studies were performed on animals aged
between 6 and 9 months. Repeated bladder cathe-
terizations of five stage-I animals at 3-day intervals
for up to 3 weeks did not result in increasing pro-
teinuria.
The rate of protein excretion measured on urine
obtained by bladder catheterization in 30 stage-I fe-
male rats aged 6 to 9 months was 46.1 31.1 1ugI
mi Inulin clearance in these animals was 2.95
0.42 ml/min, so that protein excretion averaged 15.7
g/ml GFR.
In three stage-I rats, when urine was collected
separately from the two kidneys, GFR and protein
excretion rates were similar for right and left kid-
neys. In a further group of nine stage-I rats, when
urine was collected from one kidney through a blad-
der catheter and from the second kidney via a ure-
teral catheter, values for GFR for the two kidneys
were comparable. The protein content of the blad-
der urine, however, was consistently and signifi-
cantly higher than that of the ureteral urine (Table
1). The average value for total protein excretion
from these animals (33.1 g/min) did not differ sig-
nificantly from that observed in the stage-I animals
in which urine from both kidneys was obtained
through a single bladder catheter (see above). The
carbohydrate content of the protein in pooled ure-
teral and bladder urines averaged 6.3 and 11.1 pg
per 100 g protein, respectively. In addition there
was a strong periodic acid-Schiff positive a-globulin
band seen in the protein of ureteral urine. We attrib-
ute the difference between protein content of blad-
der and ureteral urine (16.1 15g/min or almost half
the total protein excretion) to the addition of protein
to the urine in the bladder. This added protein ap-
pears to consist of mucoprotein and probably was
of tissue rather than of plasma origin.
(2) Stages-Il and -III studies. Protein excretion
rates in the 24 animals studied in stage II and again
in stage III are shown in Table 2. The 11 animals
with unilateral pyelonephritis had similar results in
both stages II and III to those from the 13 animals
with surgical reduction of renal mass, and there
were no statistically significant differences when
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TabI1. ConWarison of glomerular filtration and protein excretion rates of urine collected individually from the two kidneys
of normal ratsa
Rat
no.
GFR
mi/mm
Protein excretion rate
g/min
Bladder (L) Ureter (R) Bladder (L) Ureter (R) (L + R) (L — R)
1 1.21 1.16 19.3 9.8 29.1 9.5
2 1.07 1.21 34.3 6.0 40.3 28.3
3 0.98 0.99 9.7 2.2 11.9 7.5
4 0.76 0.76 13.7 4.7 18.4 9.0
5 1.46 1.86 31.0 10.7 41.7 20.3
6 1.35 1.59 21.8 3.7 25.5 18.1
7 1.48 1.65 17.0 13.7 30.7 3.3
8 1.49 1.41 35.7 11.5 47.2 24.2
9 1.63 1.54 38.5 14.3 52.8 24.2
Mean 1.27 1.35 24.6 8.5 33.1 16.1
±SD ±0.29 ±0.35 ±10.5 ±4.5 ±13.5 ±8.9
P NS <0.001 <00Jlb
a Urine from the right kidney (R) was collected from a catheter placed in the right ureter, the ureter being tied off distal to the site of
insertion of the catheter. Urine from the left kidney (L) was obtained through a catheter inserted into the bladder per urethra. L + R
represents total protein excretion in each animal. L — R, the difference in protein excretion between bladder and ureteral urines, is an
indication of the amount of protein added to the urine in the bladder.
bSignificance of difference from zero.
values from these two groups of animals were com-
pared. Similarly, the results from animals in which
the experimental kidneys were produced by sub-
total nephrectomy were comparable to those from
animals subjected to selective ligation of branches
of one renal artery. In view of this, results from all
three groups of animals are discussed together.
In stage II, the mean value for GFR in the control
kidneys was 1.69 ± 0.31 mI/mm, whereas it was sig-
nificantly reduced to 0.45 ± 0.15 mllmin (P < 0.001)
in the contralateral experimental kidneys. In con-
trast, protein excretion rates from the control and
experimental kidneys were similar, averaging 46.6
± 43.6 and 32.4 ± 17.5 g/min, respectively. This
might suggest that protein excretion per nephron
was higher in the experimental than in the control
kidneys. To enable, however, the experimental kid-
neys to be studied on two occasions, in stage II and
again in stage III, we had to obtain urine from these
kidneys in stage II by bladder catheter, whereas we
could collect urine from the control kidneys through
ureteral catheters. Because of the apparent addition
of protein to urine in the bladder (see above), this
protocol resulted in overestimation of protein ex-
cretion from the experimental kidneys in stage II.
When proteinuria from the experimental kidneys
was corrected for the amount of protein added in
the bladder (16.1 jsg/min, see Table 1), protein ex-
cretion rates (expressed per milliliter of GFR) from
the control and experimental kidneys were com-
parable in both the pyelonephritic and remnant ani-
mals (Fig. 1).
Every animal demonstrated a marked increase in
protein excretion from the experimental kidney
(Table 2) when studies were repeated 10 to 14 days
alter the contralateral normal kidney had been re-
moved (stage III). The increments varied from 55%
to more than 1000% (mean 356%), with the average
rate of protein excretion from the experimental kid-
neys in the 24 animals increasing from the stage II
value of 32.4 ± 17.5 p.g/min to 147.9 ± 79.0 jsg/min
in stage III (P < 0.001). Again the true increments
in protein excretion from the experimental kidneys
going from stage II to stage III were even greater
than the values shown in Table 2, because urine
from the experimental kidneys was collected
through bladder catheters in stage II but through
ureteral catheters in stage III. GFR in the experi-
mental kidneys increased an average of 47.6%, from
0.45 ± 0.15 mL1min in stage II to 0.66 ± 0.28 mllmin
in stage III (P <0.001). Even when proteinuria was
expressed per ml of GFR, however, it increased 563
and 468%, respectively, from the pyelonephritic
and remnant kidneys going from stage II to stage III
(for both values, P < 0.001; Fig. 1). Thus, the in-
creases in proteinuria were greatly in excess of the
concomitant increases in GFR. Increments from the
pyelonephritic and remnant kidneys were not signif-
icantly different from one another.
(3) Additional studies. Further studies were un-
dertaken in an attempt to define the mechanism re-
sponsible for the increased protein excretion ob-
served from the experimental kidneys when animals
were converted from stage II to stage III.
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Table 2. GFR and rates of protein excretion in rats with experimental unilateral pyelonephritis or experimental unilateral reduction in
nephron population before (stage 11) and after (stage 111) removal of the contralateral normal kidneya
Rat
no.
GFR
mI/mm
Protem excretion rate
p.g/min
Control
kidney
Stage II
Experimental kidney Control
kidney
Stage II
Experimental kidney
-——
Stage II Stage III
______________________
Stage II Stage III
Unilateral pyelonephriris
10 1.25 0.35 0.63 55.0 19.5 125.2
11 1.93 0.22 0.34 43.5 28.8 87.8
12 1.35 0.19 0.39 27.0 7.2 36.5
13 1.52 0.56 0.88 23.5 26.7 86.0
14 2.34 0.39 0.48 165.0 35.5 270.8
15 1.82 0.64 0.93 114.7 17.3 151.7
16 2.06 0.57 0.77 164.0 91.0 296.7
17 1.92 0.53 1.24 10.8 26.0 130.0
18 1.01 0.38 0.56 36.7 32.5 251.8
19 1.98 0.46 0.59 19.5 21.2 152.5
20 1.71 0.25 0.33 19.7 41.5 276.8
Mean 1.72 0.41 0.65 61.8 31.6 162.9
±SD ±0.40 ±0.15 ±0.28 ±58.1 ±21.8 ±88.5
P <0.001 <0.005
Unilateral reduction of renal mass
NS <0.001
21 1.30 0.22 0.38 7.3 15.3 60.8
22 1.58 0.81 0.92 56.2 49.2 160.8
23 1.66 0.48 0.75 57.3 56.3 178.8
24 1.66 0.46 0.29 25.2 25.3 168.2
25 2.12 0.49 0.63 32.7 37.8 258.8
26 1.59 0.52 0.93 12.7 31.0 125.5
27 1.84 0.39 0.26 81.0 19.0 199.8
28 1.86 0.36 0.45 35.7 42.0 66.8
29 1.81 0.45 0.73 31.0 37.0 226.3
30 1.45 0.37 0.61 34.8 50.3 95.8
31 1.50 0.68 1.22 36.1 20.9 92.9
32 1.46 0.49 0.81 18.8 31.5 62.8
33 1.80 0.62 0.82 9.6 14.3 45.2
Mean 1.66 0.49 0.68 33.7 33.1 134.0
±so ±0.24
<0,001
±0.15 ±0.28
<0.005
All animals
±22.1
NS
±13.8 ±69.7
<0.001
Mean 1.69 0.45 0.66 46.6 32.4 147.9
±so ±0.31 ±0.15 ±0.28 ±43.6 ±17.5 ±79.0
a Unilateral reduction of nephron population was accomplished in animals 21 through 29 by selective ligation of several branches of the
renal artery to one kidney and in the remaining animals by excision of the upper and lower poles of the kidney. Urine from the remnant
kidneys was collected by bladder catheter in stage II and by ureteric catheter in stage III. Urine from the control kidneys in stage II was
obtained through a ureteric catheter.
(a) Effects of osmotic diuresis. To examine the
possible contribution of urea and/or poorly reab-
sorbed solutes to the increased rates of protein ex-
cretion in the stage-Ill animals, we examined the
effects on protein excretion of mannitol, urea, and
sulfate infusions in stage-I rats. No significant
changes in protein excretion rates were observed
with the infusion of either mannitol (eight rats) or
urea (four rats) in amounts sufficient to increase the
fractional excretion of both sodium and water to
above 10%. Similarly the infusion of sodium sulfate
(five rats) at a rate sufficient to increase serum sul-
fate concentrations to approximately 20 mEq/liter
did not result in any significant increase in protein
excretion.
(b) Effects of extracellular fluid volume expan-
sion. Because certain of the changes in proximal
tubular function in the uremic state resemble those
observed in normal animals during saline loading
[16], the effects of extracellular fluid (ECF) vol-
ume expansion on protein excretion were studied in
six stage-I rats. After appropriate hydropenic con-
trol periods, a Ringer solution, containing inulin in
the appropriate concentration, was infused at a rate
of 190 p1/mm for 20 mm, 380 pJ/min for 20 mm, 760
p1/mm for 20 mm, and finally at a maintenance rate
of 380 1.d/min. GFR increased consistently, the
mean value rising from 2.25 ± 0.45 ml/min to 2.87 ±
0.36 mllmin (P < 0.005). There was, however, no
significant change in protein excretion, the mean
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tocol had to be omitted because the animals could
not tolerate this high rate of infusion with a protein-
containing solution.) The protein-containing solu-
tion was then replaced by Ringer's solution contain-
ing inulin given at 380 t1Jmin. After a further 20
mm, two or three urine collections, each of 20 mm's
duration, were obtained.
This protocol resulted in volume expansion with-
out any significant change in plasma protein con-
centration. Fractional excretion of sodium in-
creased from 0.5 to 6.3%. Although GFR in the 17
stage-I rats that were studied increased significantly
by an average of more than 30%, there was no in-
crease in proteinuria (Table 3).
(d) Unilateral nephrectomy. Protein excretion
and GFR were measured from one kidney in each of
seven stage-I rats using a ureteral catheter for urine
collection. Thereafter, the ipsilateral kidney was re-
moved and studies were repeated 10 to 14 days later
on the remaining kidney (stage IA), urine being col-
lected once again through a ureteral catheter. The
mean value for single kidney GFR (Table 4) in the
stage-I study was 1.36 0.16 ml/min; after unilater-
GFR
mi/mm
Plasma protein
gilOOmi
Urine protein
g/min
Before expansion
After expansion
P(pairedt test)
2.86
3.73
<0.001
6.42
6.20
NS
19.5
10.7
18.5
NS
Rat
no.
Single
—
kidney GFR
mi/mm
._—____
Single kidney
protein excretion
pg/min
Stage I Stage IA Stage I Stage IA
34 1.30 1.53 6.2 37.8
35 1.48 1.95 7.3 12.5
36 1.35 2.01 12.2 27.5
37 1.36 2.17 5.2 10.5
38 1.46 2.14 25.2 48.8
39 1.04 1.46 4.3 7.8
40 1.50 2.18 6.5 29.5
Mean 1.36 1.92 9.6 24.9
P <0.001 <0.02
GFR
0.65
GFR
0.68
GFR
1.66 0.49
250
KIDNEYS
Normal
200
Control
Experimental
150
C0
0
.E 100
0
GFR
50 1.72 0.41
GFR
1.48 /
Stage I II Iii 11 111
Normal Pyelonephritis Reduced renal massIN=30) lN11l IN=131
Fig. 1. Rates of protein excretion expressed per milliliter of GFR
observed in normal rats and in rats studied sequentially in stage
II and again in stage III. The values for GFR are expressed per
kidney. Thus GFR in stage—I rats averaged 2.96 mI/mm/animal;
for stage—I! pyelonephritic animals, 2.13; and for stage—I! ani-
mals with reduced renal mass, 2.15 mllminlanimal. Because
urine from the stage-I animals and from the remnant kidneys in
stage II were collected by bladder catheterization, the estimated
amounts of protein added to the urine in the bladder (see Table 1
and text) were subtracted from the total protein excretion rates
before excretion was factored by GFR.
values before and after expansion being 23.5 13.3
and 23.0 7.4 pg!min, respectively (P < 0.5).
(c) Increasing GFR per nephron. Although GFR
per nephron was increased by ECF volume expan-
sion in the preceding series of studies, there was a
concomitant decrease in serum protein concentra-
tion from 6.22 0.58 to 5.30 0.78 g/100 ml. This
could have masked any effect of increased GFR per
nephron on protein excretion. This possibility was
explored by volume expanding the animals with a
protein-containing solution.
Plasma was obtained from donor rats and was
added to the solution used for ECF volume expan-
sion, the concentration of plasma protein in the in-
fusion solution being adjusted so that animals re-
ceived 0.9 ml plasma per 100 g body wt in 1 hour.
After completion of two or three control urine col-
lections obtained under hydropenic conditions, the
protein containing expansion solution was infused
at 190 j.tl!min for 20 mm and then continued at 380
p11mm for 1 hour. (The 20-mm period of infusion at
760 p1/mm used in the ECF volume expansion pro-
Table 3. Influence of an increase in GFR per nephron on urine
protein excretion in 17 stage-I rats
Table 4. Effect of unilateral nephrectomy on GFR and on protein
excretion in single kidneys of normal ratsa
Measurements were made on the right kidney in normal rats
(stage I), and this kidney was subsequently removed. Stage-IA
studies were performed 10 to 14 days later on the left kidney. All
urine samples were collected through ureteral catheters. Values
of P were derived from the paired t test.
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al nephrectomy it was 1.92 0.30 mllmin, an in-
crease of 41% (P < 0.001). Although the stage-IA
rats were not azotemic, protein excretion per kid-
ney increased in every animal by up to 5 10%. The
mean value for the animals in stage I was 9.6 7.3
gImin and increased in stage IA to 24.9 15.4 pgI
mm (P < 0.02).
Qualitative protein studies: (1) Electrophoresis.
Electrophoresis of the urinary protein in stage-I and
stage-Il animals demonstrated that the major com-
ponent was albumin (Table 5). In contrast, albumin
constituted a much smaller percentage of total uri-
nary protein in stage-Ill animals, these urines con-
taining greatly increased quantitites of globulins. In-
deed, the stage-Ill urine protein had an elec-
trophoretic pattern resembling that of serum.
(2) Column chromatography. Additional charac-
terization of the urinary proteins was undertaken
using column chromatography with Sephadex G-
200, which separated the protein in rat serum and
urines into three easily defined peaks (Fig. 2). The
elution of '251-albumin from these columns indicated
that the smaller molecular-weight protein, eluted in
the third peak, consisted principally of albumin.
In accordance with the results obtained by elec-
trophoresis, the elution pattern of proteins from
stage-Ill urine samples resembled more closely that
of serum than it did that of normal (stage I) urine.
Thus, in stage-I animals, 82.6% of the urinary pro-
tein was eluted in peak 3 (Table 5). In contrast, in
the stage-Ill animals, urine protein in peak 3 aver-
aged only 40% of total protein, with the larger pro-
teins eluted in peaks 1 and 2, representing a corre-
spondingly greater proportion of total urine protein.
Indeed, the percentage of urine protein in peak 1
represented only 4.1% of total protein in stage I but
Table 5. Summary of the qualitative protein studies performed on serum and urine proteins obtained from stage-I, -II and -III ratsa
Urine
% of total protein
Serum
% of total protein
Stage I Stage II Stage IIIStage I Stage II' Stage III
Protein electrophoresis
Albumin 62.0(3) 60.2(3) 44.7(3) 47.7(8) 41.7(3) 31.6(3)
a Globulins 21.3 20.7 18.8 19.0 22.8 28.3
Globulins 10.4 12.3 19.2 23.2 21.9 25.0
yGlobulins 6.3 6.8 17.3 10.1 13.6 15.0
Column chromatography
Peak 3 82.6(4) NP 40.0 (3) 44.8(4) NP 30.1(3)
Peak2 13.3 NP 40.9 44.2 NP 53.1
Peak 1 4.1 NP 19.1 11.0 NP 16.8
Immunologic albumin
75.2(6) 55.3(5) 42.5(4) 43.2(3) 42.1(3) 33.2(3)
a The numbers in parentheses indicate the number of observations. NP means studies not performed.
' Remnant kidney with bladder urine collection
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Fig. 2. Typical result obtained when serum and pooled concen-
trated urine from normal rats was subjected to column chroma-
tography on Sephadex G-200. Trace quantities of 125I-labeled bo-
vine serum albumin was added to the serum and urine before
chromatography to permit identification of the albumin peak.
The separation of protein into three well-defined peaks is readily
apparent with albumin being eluted in this third peak. The major-
ity of the protein in normal urine was eluted in this third peak
with little larger-molecular-weight protein being present. In con-
trast, normal serum contained a higher proportion of the larger
and intermediate sized proteins, with albumin representing a
smaller percentage of total protein.
10 20 30 40 50
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was increased almost five-fold to 19.1% of total
urine protein in stage III. Because total urine pro-
tein excretion in stage-Ill animals was greater than
three times that found in stage-I animals, the abso-
lute excretion rate of the large-molecular-weight
proteins eluted in peak 1 was more than 15 times as
great in the stage-Ill as it was as in the stage-I ani-
mals.
(3) Immunologic measurements of albumin. This
measurement confirmed the electrophoretic and
chromatographic findings (Table 5). Albumin repre-
sented an average of 75.2% of total protein in stage-
I urine but comprised only 42.5% of the total pro-
tein in stage-Ill urine. Even though albumin repre-
sented a smaller percentage of total urine protein in
the stage-Ill animals, the absolute excretion rates of
albumin in the urine of these animals were still in-
creased markedly above control levels.
The immunologic values for serum albumin
showed excellent agreement with those obtained by
electrophoresis and column chromatography (as-
suming peak 3 consists of albumin). Although the
correspondence for urinary albumin determinations
obtained by the three methods in each stage was not
as close as the serum values, the differences were
not statistically significant and may have resulted
from each of the values being derived from separate
groups of rats, no individual urine being analyzed
by more than one method.
Glomerular permselectivity. Forty studies of gb-
merular permselectivity to 1251-PVP were performed
on 21 stage-I rats. Permselectivity in these normal
rats (Fig. 3) was similar to that in the normal human
[11]. PVP molecules with a radius of 60 A1 or great-
er were virtually excluded from the urine. The
clearances of smaller molecules were inversely re-
lated to molecular size with molecules less than 20
A in radius, having a clearance equal to that of in-
ulin which had an Rs of from 15 to 17 A.
In stage-Il rats, permselectivity curves for the
control and experimental kidneys were identical.
Both were shifted slightly to the right of normal, but
the differences from normal were not of statistical
significance. In animals, however, with a 50% or
greater reduction in nephron population (stages
IA and III), permselectivity was markedly abnor-
mal. In both of these groups of animals, PVP-to-
l The molecular radius of each fraction of PVP was calculated
from its elution volume from Sephadex G-200 columns. These
calculations assume that PVP is spherical in shape, and the radi-
us given is that of a sphere of equivalent size (Rs). A detailed
discussion of these calculations is presented elsewhere [11].
inulin clearance ratios for PVP molecules ranging in
size from 20 to 45 A radius were significantly ele-
vated (Table 6). These higher values resulted in the
permselectivity curves being shifted significantly to
the right of the normal curve (that for the stage-Ill
animals is shown in Fig. 3).
The studies of permselectivity from the stage-IA
and stage-Ill rats were analyzed further to deter-
mine whether the magnitude in the change from
normal of the permselectivity curves could be cor-
related to the severity of reduction in GFR. Al-
though PVP-to-inulin clearance ratios tended to be
higher in the stage-Ill animals than they were in the
stage-IA animals (Table 6), none of these dif-
ferences was of statistical significance. The stage-
III animals were then divided into three groups: (1)
GFR, >1.0 ml/min; (2) GFR, 0.5 to 1.0 mllmin; (3)
GFR, <0.5 mllmin. No significant differences were
0
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Fig. 3. Summary of the patterns of glomerular permselectivity
observed in 40 studies on stage—I and 43 studies in stage—Ill rats.
PVP-to-inulin clearance ratios are plotted against molecular
radius (Rs) of the PYP. The ratios obtained from the stage—Ill
rats were then compared to those from the stage—I animals for
each size of PVP molecules, using Student's t test
(***P < 0.001; P = <0.005; * <0.05). The significant in-
crease in the glomerular permeability observed in the stage-Ill
rats is readily apparent with the mean curve obtained from these
animals being shifted to the right of normal.
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Table 6. Comparison of PVP-to-inulin clearance ratios in rats in stages I, IA, and LIP
PYP clearanceb
Molecular size (Rs) of PVP
A
% mu/in clearance
Stage I Stage IA
----------______________________
Stage III
Mean (range) (N = 40) (N = 10) (N = 43)
20.0(18.8to21.2) 90.7 4.2 97.5 5.0 (NS)b 110.5 5.1 (<0.01)
22.5 (21.3 to 23.7) 76.7 1.7 94.4 8.0 (<0.05) 85.3 4.0 (<0.05)
25.0(23.8to26.2) 59.1 3.0 78.2 5.1 (<0.005) 80.7 3.0(<0.001)
27.5 (26.3 to 28.7) 37.0 2.0 54.2 5.1 (<0.001) 59.7 2.5 (<0.001)
30.0(28.8to31.2) 25.1 1.5 35.0 3.1 (<0.02) 41.2 2.0(<0.001)
32.5 (31.3 to 33.7) 17.0 1.0 23.5 2.2 (<0.005) 26.9 1.1 (<0.001)
35.0 (33.8 to 36.2) 13.0 0.8 16.9 1.7 (<0.02) 19.0 0.8 (<0.001)
37.5 (36.3 to 38.7) 8,9 0.5 12.3 1.2 (<0.005) 12.8 0.8 (<0.001)
40.0(38.8 to 41.2) 6.6 0.4 8.9 0.8 (<0.02) 9.1 0.5 (<0.001)
42.5 (41.3 to 43.7) 5.2 0.3 5.8 0.5(NS) 5.8 0.3(NS)
45.0(43.8 to 46.2) 3.6 0.2 4.7 0.5 (<0.05) 4.2 0.3(NS)
47.5 (46.3 to 48.7) 2.3 0.2 2.8 0.3 (NS) 2.7 0.2 (NS)
50.0 (48.8 to 51.2) 1.9 0.2 2.2 0.3 (NS) 1.8 0.1 (NS)
a All values mean SEM. N is number of studies.
b Values for P are shown in parentheses and were calculated by Student's t test for independent variables comparing results from
stages IA and III with those from stage I. NS signifies not significant (P> 0.05). There were no significant differences when results from
stage IA were compared with those from stage III.
observed when the PVP-to-inulin clearance ratios
from the three groups were compared (Fig. 4).
Permselectivity curves obtained from stage-Ill
animals with pyelonephritis were comparable to
those from animals with either subtotal nephrecto-
my or partial infarction.
________________
In both the stage-IA and stage-Ill animals, the in
________
creases in PVP-to-inulin clearance ratios varied for
different sized PVP molecules. Molecules of ap-
proximately 30 A radius showed the greatest per-
centage increase in clearance in both groups of ani
________________
mals (Fig. 5). In these studies, PVP clearances were
factored by the clearance of inulin, which had an Rs
of 15 to 17 A, to permit comparison of results from
animals with different sizes of nephron populations.
It is obvious, however, that there were significant
increases in GFR per nephron in both stage-IA and
stage-Ill animals (Tables 2 and 4 Fig. I). Thus,
the absolute increases from normal in PVP clear-
ances per nephron in the stage-IA and stage-Ill kid-
neys were even greater than those depicted in Fig.
5.
Glomerular polyanion. Kidneys from animals in
stages I, IA, and III showed comparable degrees of
staining for glomerular polyanion. Similar results
were obtained when kidneys were stained with ei
__________________________
ther alcian blue or colloidal iron. The mean score
for 32 stage-I animals whose kidneys were eval-
uated using both staining agents was 3.59 1.11. It
was 3.75 0.52 for the 20 stage-IA animals studied
similarly and 3.72 1.15 for the 21 stage-Ill ani-
100
8
__ __ __ __ __
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Fig. 4. Comparison of permselectivity patterns from animals in
which the degree of nephron reduction was of varying severity.
Details are given in Fig. 3. No significant differences were found
when the results from each of the groups of rats were compared.
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Fig. 5. Percentage changes in PVP—to—inulin clearance ratios for
PVP molecules of different sizes. The values from the stage—IA
and stage—Ill rats are compared to those from stage—I rats
mals. None of these values was significantly dif-
ferent from any other.
Serum protein concentrations. The mean serum
protein concentrations in the stage-I, -II and -III
rats were 5.8 0.7, 5.8 0.6, and 5.6 l.0g/100
ml, respectively. These values did not differ signifi-
cantly from one another.
Arterial blood pressure. Mean arterial blood pres-
sure (MABP) averaged 124 mm Hg in normal rats
and 117 mm Hg in stage-IA animals. In the stage-Ill
rats, MABP was elevated to a mean of 143 mm Hg
in animals with pyelonephritis and elevated signifi-
cantly to a mean of 157 mm Hg in those animals in
which the remnant kidneys were produced by par-
tial infarction. It was normal, averaging 118 mm Hg,
in stage-Ill animals subjected to subtotal nephrecto-
my.
Discussion
These studies were undertaken in an attempt to
define the mechanisms responsible for the protein-
uria observed in nonglomerular renal disease, par-
ticularly pyelonephritis. Proteinuria may result
from several basic mechanisms [17]. These include
(a) alterations in glomerular function that permit in-
creased passage of plasma proteins across the gb-
merular barrier, (b) decreased tubular reabsorption
of filtered protein, (c) an increase in the concentra-
tion of serum protein which results in filtration in
amounts sufficient to saturate tubular reabsorption,
(d) increased loss of low-molecular-weight protein
from the plasma, and (e) increased addition to the
urine of proteins not derived from the plasma fil-
trate. The quantitative and qualitative studies of
both plasma and urine proteins indicated that mech-
anisms other than c, d, and e were responsible for
the increased proteinuria seen in the stage-Ill rats.
Neither total nor individual components of plasma
protein concentration were increased in the stage-
III animals. Albumin and larger molecular-weight
proteins, rather than low-molecular-weight pro-
teins, accounted for the increased losses of protein
in the urine of these animals, and the urinary albu-
min was indistinguishable from that in the plasma
when characterized by immunologic, electrophoret-
ic, and column chromatographic techniques.
Rather, the data obtained suggest that the pro-
teinuria may be due in substantial degree to adapt-
ive events in the surviving nephrons that are initi-
ated by a reduction of total nephron population.
Thus, the protein excretion from kidneys with ex-
perimental pyelonephritis increased five-fold when
the nephron population was markedly reduced by
removing the contralateral normal kidney.
It is unlikely that this can be attributed to pro-
gression of the disease itself. It occurred in an inter-
val of only 2 weeks at a time when the disease had
stabilized and there was a concurrent increase in
GFR. In support of this are the data from the ani-
mals with remnant kidneys. In these rats, the exper-
imental kidneys had approximately 15 to 25% of
their original renal mass, but the residual paren-
chyma was essentially free of pathologic altera-
tions. The rates of protein excretion from the exper-
imental kidneys in stage-H remnant animals, how-
ever, were quantitatively similar to those of the
stage-Il pyelonephritic rats. When the control kid-
ney was removed from each of the remnant ani-
mals, protein excretion, both in absolute terms and
per unit of GFR, increased in a manner entirely
analogous to that observed in the stage-Ill pyebo-
nephritic rats.
Further evidence in support of the role of adapt-
ive changes, rather than pathologic changes, in the
mediation of increased protein excretion, is ob-
tained from the normal animals in which protein ex-
cretion rates were measured before and after unilat-
eral nephrectomy. Reducing the nephron popu-
lation by 50% was followed by a 40% increase in
GFR in the remaining kidneys and by an almost
three-fold increase in protein excretion. in addition,
40 45
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these studies demonstrate that the increased protein
excretion is not dependent on the biochemical
changes that occur with azotemia, the animals with
unilateral nephrectomy maintaining normal levels
of blood urea nitrogen.
One of the most striking adaptive changes that
occurs when nephron population is reduced, is a
marked increase in GFR per nephron in the residual
nephrons [6, 18]. This was observed in the present
study and theoretically could have been responsible
for the increase in proteinuria in the stage-IA and
stage-Ill rats. Normally, protein is filtered through
the rat glomerulus in low concentrations [1, 19, 20].
For any given concentration of filterable protein
molecules in the plasma, a sustained increment in
GFR should increase the amount of protein filtered.
If the tubular reabsorption of protein [1, 20, 21]
does not increase or increases proportionately less
than the increase in the filtered load of protein, it
would result in an increment in proteinuria. The
failure of ECF volume expansion to increase pro-
teinuria despite an increase in GFR and stable
serum protein demonstrates that an increase in
GFR per nephron alone is insufficient to increase
proteinuria.
This, however, does not exclude a glomerular
mechanism for the increased proteinuria seen in
stage-IA and stage-Ill animals. The mechanisms by
which GFR increases in these animals is different
from that of volume expansion. Normally, filtration
pressure equilibrium occurs before the end of the
glomerular capillary, volume expansion resulting in
disequilibrium along the length of the capillary bed
[22]. This may not alter glomerular permeability to
protein, and indeed experiments have shown that
such changes are associated with a relative de-
crease rather than an increase in permeability to un-
charged molecules the size of albumin [23]. In con-
trast, filtration pressure equilibrium still occurs in
animals with a reduced renal mass despite the oc-
currence of adaptive increases in GFR [24]. In these
animals, the increased GFR results primarily from
increases in glomerular plasma flow (QA) and mean
transcapillary hydraulic pressure difference (zP)
[24]. Such changes could be associated with an al-
tered permeability of the filtering membrane to pro-
tein. In consequence, the filtered load of protein
could increase out of proportion to the increment in
GFR. This possibility was explored by measure-
ment of glomerular permselectivity to PVP in rats
with normal and reduced complements of nephrons.
Animals with reduced renal mass did have signifi-
cant alterations in the pattern of permselectivity. In
both stage-IA and stage-Ill rats, the clearances of
PVP molecules ranging in size from approximately
20 to 40 A increased to a greater extent than the
concomitant increases in GFR. These molecules are
similar in size to the albumin molecule (R, 35 A)
and their increased clearances imply that there
could also be increased glomerular permeability to
albumin. Thus, it may not be coincidence that the
stage-Ill rats had greater increases in the clearances
of PVP molecules 30 to 35 A in size and greater in-
creases in proteinuria than did the stage-IA rats.
If this explanation for the increased albuminuria
is correct, there are at least two possible mecha-
nisms which could have resulted in the increased
clearances of larger molecular-weight proteins ob-
served in the animals with reduced renal mass. One
is that glomerular permeability to these proteins
was increased also. Alternately, if the tubular reab-
sorption of protein is nonselective, an increased fil-
tration of albumin would result in increased urinary
excretion of all proteins. Thus, the situation in
stage-IA and stage-Ill rats could be comparable to
that in man where the infusion of albumin results in
the increased urinary excretion of globulins as well
as albumin [25].
The sigmoid relationship between the relative
clearance of a polymer and its molecular size, as
well as the straight line graph which results when
the clearance data are subjected to probit transfor-
mation, has been interpreted as indicating normal
distribution of effective membrane porosity in the
normal kidney [17]. Logarithmic transformation of
the clearance data from our rats also resulted in
straight line plots; the regression lines, however, for
the stage-IA and stage-Ill animals were shifted to
the right of normal (Fig. 6). If the interpretation of
Hardwicke et al is correct [17], these results would
indicate that animals with reduced renal mass also
had a normal distribution of membrane porosity but
that 'effective pore size" was increased from nor-
mal. Such a change could increase the permeability
of the membrane to proteins and account for the in-
creased proteinuria observed in the animals with re-
duced renal mass.
More recently, mathematic models have indicat-
ed that when glomerular filtration occurs by dif-
fusion as well as by convection, permselectivity
curves will be modified not only by changes in the
properties of the capillary wall, but also by changes
in the determinants of glomerular filtration [26].
Thus, changes in QA, zP, initial g!omerular capil-
lary plasma protein concentration, and the ultra-
filtration coefficient (K1) could modify permselec-
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Fig. 6. Mean permselectivity patterns in 21 stage—I rats (40 stud-
ies) and 7 stage—IA rats (10 studies) showing the straight line
relationships between log PVP-to-inulin clearance ratios andRs,
The linear regressions were calculated after the clearance ratios
were subjected to log10 conversion, the values for slopes and in-
tercepts being those obtained from these calculations. The line
describing the results from the 43 studies in stage—Ill rats was
also displaced to the right of the stage—I results. It is not shown
on the figure to avoid confusion and had a slope of —0.063 and an
intercept of 3.435.
tivity. Such changes do not appear to explain the
altered permselectivity curves observed in our
animals with reduced renal mass. As is character-
istic in such animals [18, 24], renal blood flow to
residual nephrons (as measured by the clearance of
paraaminohippuric acid) was increased significantly
in our rats when renal mass was decreased. This, as
well as the increase in P that has been measured
after rats have been uninephrectomized, should
have altered the permselectivity curve in the oppo-
site direction to that observed [24, 26]. In addition,
plasma protein concentrations in animals with re-
duced nephron mass were not significantly different
from normal. Finally values for K have been found
to be similar in normal and uninephrectomized rats
[24]. Nor does the observation that alterations in
plasma volume modify permselectivity [23] explain
our observations. Both blood volume and inulin
spaces in stage-Ill animals are comparable to con-
trol values [27].
An increasing body of evidence indicates that the
transglomerular passage of charged molecules such
as proteins may be impeded not only by mechanical
barriers but also by the presence in the glomerular
basement membrane and on the glomerular epithe-
hal cells of the negatively charged sialoprotein gb-
merular polyanion [11, 28-33]. Even though meth-
ods were utilized that have documented loss of gb-
merular polyanion under other circumstances [29,
33], we, however, were unable to demonstrate any
loss of glomerular polyanion in stage-IA and stage-
III rats to account for the proteinuria observed in
these animals with reduced renal mass.
Other mechanisms which have been associated
with proteinuria cannot explain our observations.
Although the infusion of angiotensin will induce
proteinuria [20], hyperreninemia is not a feature of
the animal models we studied [34, 35]. Even though
hypertension alters glomerular permeability charac-
teristics [36] and may be associated with proteinuria
[37], increased urinary protein excretion occurred
in our animals irrespective of the presence or ab-
sence of hypertension.
The amount of protein excreted in the urine de-
pends on both the amount filtered at the gbomerulus
and the amount reabsorbed by the tubules. In addi-
tion to the adaptive increases in GFR per nephron
which occur when nephron population is reduced,
there are major alterations in the functional profile
of residual tubules [16]. Thus, there is a decrease in
the percentage of filtered sodium reabsorbed so that
sodium and total solute excretion per nephron in-
creased. To examine the possibility that a sustained
diuresis induced by the presence of poorly reab-
sorbable solutes in the gbomerular filtration might be
associated with the suppression of net reabsorption
of filtered protein, normal rats were subjected to the
infusion of urea, mannitol, and sulfate. Under none
of these circumstances was there a significant in-
crease in the rate of protein excretion. To examine
the effects of a reduction in fractional sodium reab-
sorption, we measured protein excretion in normal
rats before and after a saline diuresis induced by
expanding ECF volume. Despite large increments
in urine flow and sodium excretion rates, protein
excretion did not increase. Thus, the findings in the
present study are copsistent with others which in-
dicate that it is changes in glomerular filtration of
protein rather than altered tubular handling of pro-
tein which plays a more important role in the gene-
sis of proteinuria in a variety of experimental mod-
els [1, 20, 38, 39].
70
428 Proteinuria in non glomerular renal disease
Summary
The present study was designed to investigate the
mechanisms responsible for the proteinuria ob-
served in nonglomerular renal disease. In rats with
experimental unilateral pyelonephritis, protein ex-
cretion rates from the diseased and contralateral
control kidneys were similar. Protein excretion
from the pyelonephritic kidneys, however, in-
creased five-fold after the control kidneys had been
removed. Similar results were obtained in animals
with surgically induced reduction of renal mass in
one kidney. Unilateral nephrectomy of normal rats
was associated with increased protein excretion in
the urine from the remaining single kidney. Thus,
the increased proteinuria did not result from any de-
monstrable anatomic abnormalities nor was it the
consequence of the biochemical changes seen in
azotemia. No loss of glomerular polyanion could be
demonstrated in the glomeruli of animals with re-
duced renal mass. Proteinuria could not be induced
by increasing GFR per nephron, by an osmotic diu-
resis, or by saline infusion, even though the latter
maneuvers induced marked natriuresis and presum-
ably modified tubular function. The increased uri-
nary protein excretion consisted not only of albu-
min but also of larger molecular-weight proteins
with the electrophoretic characteristics of globu-
lins. Moreover, glomerular permselectivity mea-
sured from the clearances of polydisperse polyvinyl
pyrrolidone (PVP) in animals with a 50% or greater
reduction in renal mass was markedly abnormal.
The clearances of PVP molecules similar to or
greater in size than albumin were increased signifi-
cantly in excess of the concomitant increases in in-
ulin clearance. We suggest that an alteration in gb-
merular permselectivity is an integral part of the
adaptive changes which occur when nephron mass
is reduced, that this change permits an increased
passage of plasma proteins across the glomerular
barrier, and that this results in the increased pro-
teinuria observed from remaining nephrons when
total renal mass is reduced.
Acknowledgments
This work was supported in part by a Program
Project Grant (AM 09976) from the National Insti-
tute of Health. Doctor Robson was the recipient of
a Research Career Development Award (5 KO 4
AM 70236). Mrs. Brenda N. Murray provided tech-
nical assistance, and Mrs. Wanda Shaul gave secre-
tarial help.
Reprint requests to Dr. Alan M. Robson, Department of Pedi-
atrics, Washington University, 500 South Kingshighway Blvd.
St. Louis, Missouri 63110, USA
References
1. LANDWEHR DM, CARVALHO iS, OKEN DE: Micropuncture
studies of the filtration and absorption of albumin by ne-
phrotic rats. Kidney mt 11:9—17, 1977
2. KLEEMAN CR, HEWITT WL, GUZE LB: Pyelonephritis.
Medicine 39:3—116, 1960
3. DELANO BG, GOODWIN Ni, THOMSON GE, MINKOWITZ S,
FRIEDMAN EA: "Chronic pyelonephritis" as a cause of mas-
sive proteinuria (?Nephrotic syndrome.) Arch Intern Med
129:73—76, 1972
4. SHANKEL SW, ROBSON AM, BRICKER NS: On the mecha-
nism of splay in the glucose titration curve in advanced ex-
perimental renal disease in the rat. J C/in Invest 46:164-172,
1967
5. ROBSONAM, SRIVASTAVA PL, BRICKER NS: The influence
of saline loading on renal glucose reabsorption in the rat. J
Clin Invest 47:329—335, 1968
6. KAUFMAN JM, DIMEOLA Hi, SIEGAL Ni, LYTTON B,
KASHGARIAN M, HAYSLETT JP: Compensatory adaptation
of structure and function following progressive renal abla-
tion. Kidney mt 6:10—17, 1974
7. WHITE RP, SAMSON FE: Determination of inulin in plasma
and urine by use of anthrone method. J Lab C/in Med
43:475—478, 1954
8. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL Ri:
Protein measurement with the Folin phenol reagent. J Biol
Chem 193:265—275, 1951
9. CHASE MW: Production of antiserum, in Methods in Immu-
nology and Immunochemistry, edited by WILLIAMS CA,
CHASE MW, New York, Academic Press, 1967, vol. 1, pp.
197—224
10. KABAT EA, MAYER MM: Experimental Immunochemistry
(2nd ed). Springfield, Illinois, Thomas, 1961, p. 527
11. Roso AM, GIANGIAc0MO i, KIENSTRA RA, NAQVI ST,
INGELFINGER JR: Normal glomerular permeability and its
modification by minimal change nephrotic syndrome. J Clin
Invest 54:1190—1199, 1974
12. PEARSE AGE: Histochemistry (3rd ed). Boston, Little
Brown, 1968, vol. 1, p. 673
13. MICHAEL AF, BLAU E, VERNIER RL: Glomerular poly-
anion, alteration in aminonucleoside nephrosis. Lab In vest
23:649—657, 1970
14. MOWRY RW: The special value of methods that color both
acidic and vicinal hydroxyl groups in the histochemical
study of mucins. Ann NY Acad Sci 106:402-423, 1963
15. ARMITAGE P: Statistical Methods in Medical Research.
New York, John Wiley, 1973, pp. 99-118
16. BRICKER NS: The control of sodium excretion with normal
and reduced nephron populations. Am J Med 43:313-321,
1967
17. HARDWICKE J, CAMERON iS, HARRISON JF, HULME B,
SOOTH ILL iF: Proteinuria studied by clearances of individ-
ual macromolecules, inProteins in Normal and Pathological
Urine, edited by MANUEL Y, REVILLARD JP, BETUEL H,
Baltimore, University Park Press, 1970, pp. 111—152
18. BRICKER NS, KLAHR S, RIESELBACH RE: The functional ad-
aptation of the diseased kidney: 1. Glomerular filtration rate.
J C/in Invest 43:1915—1921, 1964
19. OKEN DE, FLAMENBAUM W: Micropuncture studies of
proximal tubule albumin concentrations in normal and ne-
phrotic rats. J C/in Invest 50:1498—1505, 1971
20. EISENBACH GM, VAN LIEW iB, BOYLANJW: Effect of angi-
otensin on the filtration of protein in the rat kidney: A micro-
puncture study. Kidney mt 8:80-87, 1975
Robson et a! 429
21. LEBER PD, MARSH DJ: Micropuncture study of concentra-
tion and fate of albumin in rat nephron. Am J Physiol
219:358—363, 1970
22. DEEN WM, TROY JL, ROBERTSON CR, BRENNER BM: Dy-
namics of glomerular ultrafiltration in the rat: IV. Determi-
nation of the ultrafiltration coefficient. J Clin Invest 52:1500—
1508, 1973
23. CHANG RLS, UEKI IF, TROY JL, DEEN WM, ROBERTSON
CR, BRENNER BM: Permselectivity of the glomerular capil-
lary wall to macromolecules: II. Experimental studies in rats
using neutral dextrans. Biophys J 15:887-906, 1975
24. DEEN WM, MAODOX DA, ROBERTSON CR, BRENNER BM:
Dynamics of glomerular ultrafiltration in the rat: VII. Re-
sponse to reduced renal mass. Am J Physiol 227:556-562,
1974
25. HARDWICKE J, SQUIRE JR: The relationship between plasma
albumin concentration and protein excretion in patients with
proteinuria. Gun Sci 14:509—530, 1955
26. CHANG RLS, ROBERTSON CR, DEEN WM, BRENNER BM:
Permselectivity of the glomerular capillary wall to macro-
molecules: I. Theoretical considerations. Biophys J 15:861—
886, 1975
27. SCHULTZE RG, SHAPIRO HS, BRICKER NS: Studies on the
control of sodium excretion in experimental uremia. J Clin
Invest 48:869—877, 1969
28. JONES DB: Mucosubstances of the glomerulus. Lab Invest
21:119—125, 1969
29. BLAU EB, HAAS JE: Glomerular sialic acid and proteinuria
in human renal disease. Lab Invest 28:477-481, 1973
30. CHANG RLS, DEEN WM, ROBERTSON CR, BRENNER BM:
Permselectivity of the glomerular capillary wall: III. Re-
stricted transport of polyanions. Kidney mt 8:212—218, 1975
31. RENNEE HG, VENKATACHALAM MA: Glomerular per-
meability: In vivo tracer studies with polyanionic and poly-
cationic ferritins. Kidney Int 11:44—53, 1977
32. SELLER MW, RENNKE HG, VENKATACHALAM MA, COTRAN
RS: Pathogenesis of polycation-induced alterations ('fu-
sion") of glomerular epithelium. Lab Invest 36:48—61, 1977
33. ROOT ER, CONLEY SB, ROBSON AM: Effect of glomerular
polyanion removal On proteinuria (abst). Pediatr Res 11:555,
1977
34. SOKABE H, GROLLMAN A: A study of hypertension in the rat
induced by infarction of the kidney. Texas Rep Biol Med
21:93-100, 1963
35. PURKERSON ML, HOFFSTEN PE, KLAHR S: Pathogenesis of
the glomerulopathy associated with renal infarction in rats.
Kidney Int 9:407—417, 1976
36. GERMUTH FG JR, KELEMAN WA, POLLACK AD: Immune
complex disease: II. The role of circulatory dynamics and
glomerular filtration in the development of experimental gb-
merulonephritis. Johns Hop Med J 120:252—261, 1967
37. FELD LG, VAN LIEw JB, GALASKE RG, BOYLAN JW: Selec-
tivity of renal injury and proteinuria in the spontaneously
hypertensive rat. Kidney mt 12:332—343, 1977
38. OKEN DE, C0TE5 SC, MENDE CW. Micropuncture study of
tubular transport of albumin in rats with aminonucleoside
nephrosis. Kidney mt 1:3—11, 1972
39. LEWY JE, PESCE A: Micropuncture study of albumin trans-
fer in aminonucleoside nephrosis in the rat. Pediatr Res
7:553—559, 1973
